Skip to main content
Skip to content
Case File
d-31594House OversightOther

Citation of a 2014 report on female condom cost‑benefit without substantive allegations

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #027088
Pages
1
Persons
0
Integrity
No Hash Available

Summary

The passage merely references a published health‑economics report and contains no names, transactions, dates, or allegations linking powerful actors to misconduct. It offers no actionable investigativ Reference to Global Health Visions 2014 report titled “The Business Case for Female Condoms”. Two stated ROI arguments: health‑system cost savings and avoided productivity losses.

This document is from the House Oversight Committee Releases.

View Source Collection

Tags

public-healthcostbenefit-analysishouse-oversightfemale-condoms
Ask AI about this document

Search 264K+ documents with AI-powered analysis

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
1) IT IS TOO EXPENSIVE: FALSE “The Business Case for Female Condoms” (Global Health Visions, 2014) Return on investment of female condom procurement for governments through 2 ways: 1) Cost savings to the health system, by focussing on prevention instead of treatment 2) Economic productivity losses averted, as more women are able to join the workforce.

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.